Jane D E, Chalmers D J, Howard J A, Kilpatrick I C, Sunter D C, Thompson G A, Udvarhelyi P M, Wilson C, Watkins J C
Department of Pharmacology, School of Medical Sciences, Bristol, U.K.
J Med Chem. 1996 Nov 22;39(24):4738-43. doi: 10.1021/jm960382c.
All four isomers of 3-(4-chlorophenyl)glutamic acid (5-8) were prepared by diastereoselective synthesis. Addition of (6S)-(+)-bis-lactim ether 15 to cis-4-chlorocinnamate 12 gave a mixture comprising mainly the (2R,3S)- and (2R,3R)-isomers 5 and 6, respectively (in a ratio of 56:40), while addition of (6R)-(-)-bis-lactim ether 16 to 4-chlorocinnamate 12 gave a mixture comprising mainly the (2S,3R)- and (2S,3S)-isomers 8 and 7, respectively (in a ratio of 56:42). The four stereoisomers (5-8) were therefore conveniently prepared by addition of either 3-lithio-(6S)- or -(6R)-bis-lactim ether (15 or 16, respectively) to 4-chlorocinnamate 12 and separation of the resultant mixtures of diastereoisomers (23-26) by flash silica gel chromatography. The absolute configurations of 6 and 7 were confirmed by X-ray crystallography. Both the (2S,3S)- and (2S,3R)-isomers (7 and 8, respectively) at a concentration of 100 microM significantly potentiated depolarizations induced by 10 microM L-homocysteic acid (L-HCA) (% control +/- sem: 130.4 +/- 3.6, n = 20 and 114.5 +/- 2.4, n = 11, respectively) while the (2R,3S)-isomer 5 significantly reduced L-HCA response amplitude (94.2 +/- 1.4, n = 9) and the (2R,3R)-isomer 6 was inactive. Experiments designed to compare the agonist-potentiating actions of 7 and 8 in the neonatal rat spinal cord with L-trans-pyrrolidine-2,4-dicarboxylic acid, the well-known L-Glu uptake inhibitor, provided additional evidence for the selective enhancement of depolarizations due to L-HCA and not those due to L-Glu. This selective action supports the existence of multiple excitatory amino acid uptake sites.
通过非对映选择性合成制备了3-(4-氯苯基)谷氨酸的所有四种异构体(5-8)。将(6S)-(+)-双内酰胺醚15加到顺式-4-氯肉桂酸酯12上,得到分别主要包含(2R,3S)-和(2R,3R)-异构体5和6的混合物(比例为56:40),而将(6R)-(-)-双内酰胺醚16加到4-氯肉桂酸酯12上,得到分别主要包含(2S,3R)-和(2S,3S)-异构体8和7的混合物(比例为56:42)。因此,通过将3-锂代-(6S)-或-(6R)-双内酰胺醚(分别为15或16)加到4-氯肉桂酸酯12上,并通过快速硅胶柱色谱法分离所得的非对映异构体混合物(23-26),方便地制备了这四种立体异构体(5-8)。6和7的绝对构型通过X射线晶体学得到确证。浓度为100μM的(2S,3S)-和(2S,3R)-异构体(分别为7和8)均显著增强了由10μM L-高半胱氨酸(L-HCA)诱导的去极化(%对照±标准误:分别为130.4±3.6,n = 20和114.5±2.4,n = 11),而(2R,3S)-异构体5显著降低了L-HCA反应幅度(94.2±1.4,n = 9),(2R,3R)-异构体6无活性。旨在比较7和8在新生大鼠脊髓中与著名的L-谷氨酸摄取抑制剂L-反式-吡咯烷-2,4-二羧酸的激动剂增强作用的实验,为L-HCA而非L-谷氨酸引起的去极化的选择性增强提供了额外证据。这种选择性作用支持了多个兴奋性氨基酸摄取位点的存在。